These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy. Filipe WF; Meyer YM; Buisman FE; van den Braak RRJC; Galjart B; Höppener DJ; Jarnagin WR; Kemeny NE; Kingham TP; Nierop PMH; van der Stok EP; Grünhagen DJ; Vermeulen PB; Groot Koerkamp B; Verhoef C; D'Angelica MI Ann Surg Oncol; 2023 Dec; 30(13):7996-8005. PubMed ID: 37782413 [TBL] [Abstract][Full Text] [Related]
8. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Martin RC; Edwards MJ; McMasters KM Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489 [TBL] [Abstract][Full Text] [Related]
9. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases. Chakedis J; Beal EW; Sun S; Galo J; Chafitz A; Davidson G; Reardon J; Dillhoff M; Pawlik TM; Abdel-Misih S; Bloomston M; Schmidt CR J Surg Oncol; 2018 Dec; 118(7):1065-1073. PubMed ID: 30376157 [TBL] [Abstract][Full Text] [Related]
10. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study. Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919 [TBL] [Abstract][Full Text] [Related]
11. Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality. Srouji R; Narayan R; Boerner T; Buisman F; Seier K; Gonen M; Balachandran VP; Drebin J; Jarnagin WR; Kingham TP; Wei A; Kemeny NE; D'Angelica M J Surg Oncol; 2020 Jun; 121(8):1314-1319. PubMed ID: 32236970 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397 [TBL] [Abstract][Full Text] [Related]
18. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853 [TBL] [Abstract][Full Text] [Related]
19. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol. Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724 [TBL] [Abstract][Full Text] [Related]